Kiklin Sales Begin, Astellas And Sanwa Chemistry Work Together
This article was originally published in PharmAsia News
Executive Summary
Astellas began sales of a hyperphosphatemia treatment drug Kiklin (bixalomar) on June 26 in Japan for chronic renal failure patients undergoing dialysis.